Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Marshak Richard received 2,657 Trisalus Life Sciences, Inc. shares as an award (Form 5)
Traded Jun 30, 2024 to Dec 31, 2025 · Filed Jul 1, 2026
From Jun 30, 2024 to Dec 31, 2025, Marshak Richard (Chief Commercial Officer) received 2,657 Trisalus Life Sciences, Inc. shares as an award at an average US$4.31 for US$11,465, leaving 131,758 shares. Filed Jul 1, 2026 (Form 5).
- Awarded
- 2,657 shares
- Price
- US$4.31 average (US$4.23 to US$4.69)
- Value
- US$11,465
- Holding after
- 131,758 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2024 | Common Stock | Award | 279 | US$4.69 | 27,530 | Direct |
| Dec 31, 2024 | Common Stock | Award | 999 | US$4.26 | 35,404 | Direct |
| Jun 30, 2025 | Common Stock | Award | 930 | US$4.23 | 71,309 | Direct |
| Dec 31, 2025 | Common Stock | Award | 449 | US$4.38 | 131,758 | Direct |
Source
Related
- Trisalus Life Sciences, Inc.
- Marshak Richard
- Trisalus Life Sciences, Inc. shareholders
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Marshak Richard · Jul 1, 2026
- Form 4 · Marshak Richard · May 19, 2026
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Form 4 · Szela Mary T · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026
- Form 4 · Patience David · Jul 6, 2026